Only "magnificent Seven" Stocks Look Like Buys Right Now
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
Zero based budgeting can be a powerful tool for managing your finances. Assess its effectiveness to determine if it fits your personal finance needs.
15,457 articlesAmong the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Bernstein boosts its ServiceNow price target to $236 after the company's Analyst Day, underscoring margin upside even...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...
This week's Sunday reads gather practical investing lessons you can act on. From patient investing to tax strategies,...
A notable stake reduction in NMI Holdings highlights how large investors weigh growth, risk, and value. Here’s what i...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
A $100,000 investment in Dividend Kings targets $5,400 of passive income each year, reflecting durable payouts amid a...
Disney beats Q2 expectations, sending Wall Street into a target-upgrade cycle. JPMorgan, Barclays and Guggenheim lift...
In 2026 market conditions, the Vanguard High Dividend Yield ETF posted stronger five-year gains than SCHD, while deca...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...